4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-056781
Chief Executive Officer sold 4,400 shares at an average $15.02 ($66,066)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-10-11 | Sale : show line 1 in the form | −2,200 | $15.25 | $33,550 | 430,778 | I |
| 2017-10-12 | Sale : show line 2 in the form | −2,200 | $14.78 | $32,516 | 428,578 | I |
| Open-market sales · 4,400 sh · avg $15.02 · $66,066 | ||||||
Loading xslF345X03/doc4.xml…